$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Viable and high-throughput isolation of heterogeneous circulating tumor cells using tapered-slit filters

Sensors and actuators. B, Chemical, v.321, 2020년, pp.128369 -   

Shim, Jae-Eul (Cell Bench Research Center, Korea Advanced Institute of Science and Technology (KAIST)) ,  Bu, Jiyoon (Cell Bench Research Center, Korea Advanced Institute of Science and Technology (KAIST)) ,  Lee, Mi-Kyung (Cell Bench Research Center, Korea Advanced Institute of Science and Technology (KAIST)) ,  Cho, Young-Ho (Cell Bench Research Center, Korea Advanced Institute of Science and Technology (KAIST)) ,  Kim, Tae-Ha (SenPlus, Ltd.) ,  Bu, Jong-Uk (SenPlus, Ltd.) ,  Han, Sae-Won (Seoul National University Hospital)

Abstract AI-Helper 아이콘AI-Helper

Abstract Circulating tumor cells (CTCs) have received a great amount of attention, as they are known to promote metastatic spread of cancer. Despite a wide variety of techniques developed to utilize CTCs as a diagnostic and prognostic tumor biomarker, clinical trials based on CTC analysis have show...

Keyword

참고문헌 (43)

  1. Acta Pharm. Sin. B Guan 5 402 2015 10.1016/j.apsb.2015.07.005 Cancer metastases: challenges and opportunities 

  2. JNCI: Journal of the National Cancer Institute Warren 107 2015 10.1093/jnci/djv134 Challenges and opportunities in measuring cancer recurrence in the United States 

  3. Nat. Rev. Clin. Oncol. Crowley 10 472 2013 10.1038/nrclinonc.2013.110 Liquid biopsy: monitoring cancer-genetics in the blood 

  4. Lab Chip den Toonder 11 375 2011 10.1039/c0lc90100h Circulating tumor cells: the grand challenge 

  5. Aust Med J Ashworth 14 146 1869 A case of cancer in which cells similar to those in the tumours were seen in the blood after death 

  6. Trends Mol. Med. Pantel 16 398 2010 10.1016/j.molmed.2010.07.001 Circulating tumour cells in cancer patients: challenges and perspectives 

  7. Biomaterials Bu 125 1 2017 10.1016/j.biomaterials.2017.02.009 Polyester fabric sheet layers functionalized with graphene oxide for sensitive isolation of circulating tumor cells 

  8. Anticancer Res. Kolostova 34 3641 2014 Circulating tumor cells in localized prostate cancer: isolation, cultivation in vitro and relationship to T-stage and Gleason score 

  9. Clin. Cancer Res. De Bono 14 6302 2008 10.1158/1078-0432.CCR-08-0872 Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer 

  10. Breast Cancer Res. Spiliotaki 16 485 2014 10.1186/s13058-014-0485-8 Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy 

  11. Ann. Oncol. Sastre 19 935 2008 10.1093/annonc/mdm583 Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables 

  12. Clin. Oncol. Cohen 26 3213 2008 10.1200/JCO.2007.15.8923 Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer 

  13. Br. J. Cancer Lecharpentier 105 1338 2011 10.1038/bjc.2011.405 Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer 

  14. Proc. Natl. Acad. Sci. Brabletz 98 10356 2001 10.1073/pnas.171610498 Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment 

  15. Mol. Cancer Res. Armstrong 9 997 2011 10.1158/1541-7786.MCR-10-0490 Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers 

  16. Cancer Res. Yokobori 73 2059 2013 10.1158/0008-5472.CAN-12-0326 Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis 

  17. Biosens. Bioelectron. Bu 2020 10.1016/j.bios.2020.112250 Surface engineering for efficient capture of circulating tumor cells in renal cell carcinoma: from nanoscale analysis to clinical application 

  18. Anticancer Res. Desitter 31 427 2011 A new device for rapid isolation by size and characterization of rare circulating tumor cells 

  19. Cancer Detection Diag. Technol. Global Health Adams 301 983 2020 Rapid and efficient isolation of circulating tumor cells using high porosity precision microfilters 

  20. PLoS One Yusa 9 2014 10.1371/journal.pone.0088821 Development of a new rapid isolation device for circulating tumor cells (CTCs) using 3D palladium filter and its application for genetic analysis 

  21. Biosens. Bioelectron. Fan 71 380 2015 10.1016/j.bios.2015.04.080 A microfluidic chip integrated with a high-density PDMS-based microfiltration membrane for rapid isolation and detection of circulating tumor cells 

  22. Biosens. Bioelectron. Sun 102 157 2018 10.1016/j.bios.2017.11.026 High-purity capture of CTCs based on micro-beads enhanced isolation by size of epithelial tumor cells (ISET) method 

  23. Lab Chip Jiang 17 3498 2017 10.1039/C7LC00654C Microfluidic isolation of platelet-covered circulating tumor cells 

  24. Nat. Protoc. Warkiani 11 134 2016 10.1038/nprot.2016.003 Ultra-fast, label-free isolation of circulating tumor cells from blood using spiral microfluidics 

  25. Cancers Zeinali 12 127 2020 10.3390/cancers12010127 High-throughput label-free isolation of heterogeneous circulating tumor cells and CTC clusters from non-small-cell lung cancer patients 

  26. Clin. Cancer Res. Lin 16 5011 2010 10.1158/1078-0432.CCR-10-1105 Portable filter-based microdevice for detection and characterization of circulating tumor cells 

  27. Br. J. Cancer Farace 105 847 2011 10.1038/bjc.2011.294 A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas 

  28. Biomed. Microdevices Zheng 13 203 2011 10.1007/s10544-010-9485-3 3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood 

  29. Kang 2020 Tapered-slit Membrane Filter Devices for the High-Throughput Viable Isolation of Circulating Tumor Cells 

  30. J. Micromechanics Microengineering Kim 27 2017 10.1088/1361-6439/aa53ff A viable circulating tumor cell isolation device with high retrieval efficiency using a reversibly deformable membrane barrier 

  31. Oncogene Ono 31 4923 2012 10.1038/onc.2011.646 SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation 

  32. Oncotarget Liu 6 15966 2015 10.18632/oncotarget.3862 Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation 

  33. J. Biomech. Omidvar 47 3373 2014 10.1016/j.jbiomech.2014.08.002 Atomic force microscope-based single cell force spectroscopy of breast cancer cell lines: an approach for evaluating cellular invasion 

  34. RSC Adv. Bu 7 49684 2017 10.1039/C7RA09212A Enhancement of isolation sensitivity for the viable heterogeneous circulating tumor cells swelled by hypo-osmotic pressure 

  35. BMC Cancer Gorges 12 178 2012 10.1186/1471-2407-12-178 Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition 

  36. Biosens. Bioelectron. Bu 91 747 2017 10.1016/j.bios.2017.01.039 Lab on a fabric: mass producible and low-cost fabric filters for the high-throughput viable isolation of circulating tumor cells 

  37. Biol. Open Vazquez-Iglesias 8 2019 10.1242/bio.041673 Surface expression marker profile in colon cancer cell lines and sphere-derived cells suggests complexity in CD26+ cancer stem cells subsets 

  38. Oncotarget Zhao 8 9293 2017 10.18632/oncotarget.14065 Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer 

  39. Am. Soc. Clin. Oncol. Lindsay 2018 10.1200/JCO.2018.36.15_suppl.e24106 Quantification of circulating tumor cells as a biomarker for surveillance in oligometastatic patients after definitive radiation therapy 

  40. Nat. Rev. Cancer Polyak 9 265 2009 10.1038/nrc2620 Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits 

  41. Pharmacol. Ther. Jolly 194 161 2019 10.1016/j.pharmthera.2018.09.007 Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas 

  42. Expert Rev. Mol. Med. Garg 19 2017 10.1017/erm.2017.6 Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis 

  43. Front. Oncol. Jolly 5 155 2015 10.3389/fonc.2015.00155 Implications of the hybrid epithelial/mesenchymal phenotype in metastasis 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로